WASHINGTON – The U.S. Supreme Court on Thursday ruled that mifepristone, a medication used in the majority of abortions in the United States, can remain available, rejecting a challenge by antiabortion groups that sought to undo the Food and Drug Administration’s longstanding approval of the medication.